A New Jersey judge has denied a preliminary bid by shareholders of cardiovascular medical device maker Datascope Corp. to prevent the company's $841 million acquisition by Swedish medical supply company Getinge AB.
A four-lawyer administrative committee is in charge of turning out the lights at dissolving Thelen Reid Brown Raysman & Steiner LLP, the firm confirmed Friday, adding there is no plan to file for bankruptcy.
A report released by the U.S. Department of Transportation on Thursday suggests that airports with hourly flight limits are restrictive to airline competition and may spark sharp increases in domestic ticket costs.
More than a dozen major title insurers facing antitrust action that accuses the industry of conspiring with a New Jersey rating bureau to fix prices have moved to toss the suit, citing the filed rate doctrine.
A federal district judge has rejected GlaxoSmithKline PLC's plea to reconsider his refusal to dismiss a suit brought against the pharmaceutical giant over the death of a 16-year-old who committed suicide after taking the antidepressant Paxil. The judge ruled, however, that GSK should be allowed to pursue an interlocutory appeal.
A federal judge has agreed to bifurcate the trial in a patent infringement suit brought by Novartis AG to protect its hypertension drug Lotrel, writing that “the separation of issues would minimize jury confusion and promote judicial economy.”
While most patent holders are still able to secure a permanent injunction in an infringement case following the U.S. Supreme Court’s ruling in eBay Inc. v. MercExchange LLC, federal courts are no longer granting injunctions to just anybody.
A panel advising the U.S. Food and Drug Administration on the safety of bisphenol A says the agency's draft assessment of the controversial chemical was “inadequate” and failed to articulate “reasonable and appropriate” scientific support for the criteria applied to select data for use in the review.
AstraZeneca Pharmaceuticals LP hit Handa Pharmaceuticals LLC with a second infringement suit in three months Tuesday over its bid to produce a generic version of Seroquel XR.
Seven northeastern states — Connecticut, Maine, New Hampshire, New York, Rhode Island, Vermont and Massachusetts — have filed a petition with the U.S. Environmental Protection Agency under the Clean Water Act asking it to address mercury pollution from neighboring states.
Lehman Brothers Holdings Inc. on Tuesday sought to move forward with a real estate deal, entered into prior to its bankruptcy, to unload 50 acres of undeveloped land in New Jersey. The investment giant also sought extra time to disclose information about its finances.
Bush administration appointees to the U.S. Food and Drug Administration have disregarded the advice of career government officials in a push to preempt individual state tort liability cases filed in connection with pharmaceutical drugs, according to a report issued Wednesday.
San Antonio-based CPS Energy is seeking to stomp out a subpoena that would require it, a nonparty in the case, to disclose trade secrets to Avaya Inc. as part of that company's protracted suit over an alleged monopoly in the telephone maintenance industry.
A New Jersey judge has dismissed requests to revive a class action alleging that L’Oreal USA Inc. negligently manufactured lipsticks that contained dangerous amounts of lead.
Tropicana Entertainment LLC racked up over $1.1 million in fees during the month of September for services and expenses charged by the law firm representing the debtors and by the financial advisory firm counseling the unsecured creditors in the casino operator's Chapter 11 bankruptcy proceedings.
Marcal Paper Mill Inc. has filed a third amended Chapter 11 plan and disclosure statement creating a liquidating trust for the $121 million it netted from selling its assets to stalking horse bidder NexBank SSB.
A federal magistrate judge in charge of discovery in the multidistrict litigation over Eli Lilly & Co.'s Zyprexa has ordered Connecticut's attorney general to hand over the medical records of hundreds of state Medicaid patients in the ongoing battle over the marketing of the anti-psychotic drug.
Hoffmann-La Roche Inc. has fired off a lawsuit at Indian drugmaker Orchid Chemicals & Pharmaceuticals Ltd. over a newly issued patent for Roche's blockbuster osteoporosis drug Boniva Once-Monthly, even as the pharmaceutical companies spar over two other patents related to Boniva in a separate lawsuit.
A judge has rejected Abercrombie & Fitch's bid to dismiss a handful of suits alleging violations of the Fair Labor Standards Act, ruling that the complaints against the popular clothier have passed the first test for being classified as a collective action.
A woman who sued Stryker Corp. over a squeaky hip implant has lost her Colorado district court case after failing to show her claims aren't preempted, but a proposed product liability class action she helped bring in New Jersey over the same incident continues.